IIM
TMO icon

Intact Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Intact Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-430
Closed -$209K – 336
2025
Q3 		$209K Sell
430
-2,770
-87% -$1.29M 0.01% 251
2025
Q2 		$1.3M Buy
3,200
+100
+3% +$41.8K 0.04% 210
2025
Q1 		$1.54M Buy
3,100
+500
+19% +$271K 0.05% 194
2024
Q4 		$1.35M Buy
2,600
+660
+34% +$363K 0.05% 200
2024
Q3 		$1.2M Sell
1,940
-420
-18% -$249K 0.04% 194
2024
Q2 		$1.31M Buy
2,360
+260
+12% +$149K 0.05% 189
2024
Q1 		$1.22M Sell
2,100
-200
-9% -$112K 0.05% 193
2023
Q4 		$1.22M Buy
+2,300
New +$1.11M 0.05% 188
2023
Q1 		– Sell
-2,000
Closed -$1.1M – 272
2022
Q4 		$1.1M Sell
2,000
-700
-26% -$371K 0.05% 177
2022
Q3 		$1.37M Sell
2,700
-100
-4% -$56K 0.05% 182
2022
Q2 		$1.52M Hold
2,800
– – 0.05% 175
2022
Q1 		$1.66M Buy
2,800
+200
+8% +$115K 0.04% 185
2021
Q4 		$1.74M Sell
2,600
-1,000
-28% -$624K 0.04% 185
2021
Q3 		$2.06M Sell
3,600
-200
-5% -$110K 0.06% 166
2021
Q2 		$1.92M Hold
3,800
– – 0.05% 167
2021
Q1 		$1.74M Hold
3,800
– – 0.05% 175
2020
Q4 		$1.77M Sell
3,800
-400
-10% -$188K 0.06% 180
2020
Q3 		$1.85M Hold
4,200
– – 0.06% 169
2020
Q2 		$1.52M Hold
4,200
– – 0.06% 168
2020
Q1 		$1.19M Hold
4,200
– – 0.05% 172
2019
Q4 		$1.36M Buy
4,200
+2,100
+100% +$637K 0.05% 173
2019
Q3 		$612K Hold
2,100
– – 0.02% 188
2019
Q2 		$617K Hold
2,100
– – 0.02% 185
2019
Q1 		$575K Buy
2,100
+100
+5% +$24.9K 0.02% 182
2018
Q4 		$447K Hold
2,000
– – 0.02% 183
2018
Q3 		$488K Hold
2,000
– – 0.02% 192
2018
Q2 		$414K Hold
2,000
– – 0.01% 190
2018
Q1 		$413K Hold
2,000
– – 0.02% 185
2017
Q4 		$380K Buy
+2,000
New +$383K 0.02% 172

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Intact Investment Management's TMO Position: Q4 2025 in Review

Intact Investment Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 430 shares — an estimated $209K sold.

Intact Investment Management first reported a position in TMO in Q4 2017 and held it in 29 quarters. The position peaked at $2.06M in Q3 2021. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Intact Investment Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Intact Investment Management sold 430 Thermo Fisher Scientific shares in Q4 2025, an estimated $209K.
  • Intact Investment Management first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 29 quarters.
  • Intact Investment Management's Thermo Fisher Scientific position peaked at $2.06M in Q3 2021.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Intact Investment Management's 13F filing for Q4 2025, filed 2 Feb 2026.